Development and Validation of the UriMee Model: A Methylation-based Diagnostic Tool for Early Diagnosis of Urothelial Carcinoma
The UriMee test demonstrated high sensitivity and specificity, particularly in detecting early-stage tumors and UTUC, significantly outperforming traditional methods.
Authors
- Yuping Hao (ORCID: https://orcid.org/0000-0002-6821-609X)
- Tingting Zhao (ORCID: https://orcid.org/0000-0002-5848-6061)
- Wei Xue (ORCID: https://orcid.org/0000-0001-9189-4617)
- Ming Cao (ORCID: https://orcid.org/0000-0003-1509-9325)
- Na Xue (ORCID: https://orcid.org/0000-0003-4520-4122)
- Ruiyun Zhang (ORCID: https://orcid.org/0000-0003-3501-646X)
- Richard Y. Cao (ORCID: https://orcid.org/0000-0002-8743-9125)
- Lianhua Zhang (ORCID: https://orcid.org/0009-0009-3208-4177)
- Haige Chen (ORCID: https://orcid.org/0000-0002-5194-2087)
- Yang Zhang (ORCID: https://orcid.org/0000-0001-5760-8904)
- Di Jin (ORCID: https://orcid.org/0000-0002-6403-7983)
- Longfei Huang (ORCID: https://orcid.org/0009-0006-4761-7384)
- Dandan Wang (ORCID: https://orcid.org/0000-0002-9370-0668)
- Guoliang Yang
- Wei Liu (ORCID: https://orcid.org/0000-0003-2018-7004)
Institutions
- Renji Hospital (CN)
- Shanghai First Maternity and Infant Hospital (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- European Urology Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.euo.2025.03.004
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China